5-Methoxytryptamine Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: serotonin receptor and melatonin metabolism

Nootropic Compounds compound Powder verified

Also known as: 5-MT, Mexamine

Quick Facts

Reference Sizes
100 mg, 1 g, 5 g, 25 g
Storage
2-8 deg C for supplier-listed solid material; follow the lot-specific SDS and COA
Solubility
Salt-dependent; no standardized human formulation. Verify the supplier SDS for the specific free-base or salt form

Catalog Description

5-Methoxytryptamine (5-MT), also known as mexamine, is a naturally occurring tryptamine closely related to serotonin and melatonin. It is produced endogenously in the pineal gland via deacetylation of melatonin, and administration studies show 5-MT is converted back into melatonin in vivo, with pharmacokinetic curves confirming this metabolic interconversion. Receptor-binding studies show 5-MT acts as a full agonist at multiple serotonin receptor subtypes (5-HT1, 5-HT2, 5-HT4, 5-HT6, 5-HT7), with negligible affinity for 5-HT3 and only weak affinity for 5-HT1E relative to other 5-HT1 subtypes. Because of this broad serotonergic activity plus its role in the melatonin biosynthetic pathway, 5-MT has been studied as a pharmacological tool compound rather than developed as an approved therapeutic; there are no completed human efficacy trials establishing a clinical indication.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life
Not characterized in human pharmacokinetic literature
Onset
Rapid conversion to melatonin observed in pharmacokinetic model studies (within hours)
Administration Routes (Research)
Laboratory / preclinicalLocal infusion / perfusion

Reported Research Effects

Reported Research Side Effects

Data source: Pharmacology/receptor-binding literature and pineal biochemistry research

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Route-Specific Research Protocols

Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.

Label / guideline Human study Community only Preclinical only Not established
Laboratory / preclinical Not established

Animal and laboratory tool doses vary by model; no human protocol is established

Frequency / timing
Study-specific
Duration / setting
Study-specific
Technique
Laboratory model
Evidence
No established protocol

Context: published preclinical literature

Route safety: No route-specific protocol is established. Do not infer an amount from another route, component, or formulation.

Local infusion / perfusion Preclinical only

No route-specific amount established in the reviewed record.

Technique
Laboratory injection or perfusion (animal studies)
Evidence
Route noted; protocol not established

Context: The catalog identifies this route, but its reviewed sources do not establish a separate amount and schedule for it.

Formulation: Route-specific sterile formulation and professional handling requirements apply; concentration cannot be inferred from an oral or topical product.

Route safety: Non-human or laboratory exposure. It cannot be converted into a human dose.

Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.

Research Interactions

Flagged Avoid / Caution Combinations (Research)

Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.

Research Notes

Current laboratory suppliers list crystalline powder rather than standardized capsules. The avoidWith entries are theoretical safety flags based on broad serotonergic agonism because no human interaction studies establish a safe combination.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

On the significance of an alternate pathway of melatonin synthesis via 5-methoxytryptamine: comparisons across species — Journal of Pineal Research (Wiley)
https://onlinelibrary.wiley.com/doi/10.1111/jpi.12336
NCATS Inxight Drugs - 5-Methoxytryptamine — NCATS (NIH)
https://drugs.ncats.io/drug/3VMW6141KC

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top